|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.400 CNY | +2.41% |
|
+6.25% | -14.57% |
| Market Cap | 2.67B 393M 344M 317M 293M 556M 37.51B 565M 3.79B 1.49B 18.48B 1.48B 1.44B 63.53B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 2.88B 425M 372M 343M 317M 601M 40.57B 612M 4.1B 1.61B 19.98B 1.6B 1.56B 68.7B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
69.52% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.41% | ||
| 1 week | +6.25% | ||
| Current month | +14.48% | ||
| 1 month | +3.34% | ||
| 3 months | -29.31% | ||
| 6 months | -18.27% | ||
| Current year | -14.57% |
| 1 week | 3.07 |  | 3.46 |
| 1 month | 2.85 | | 3.46 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.41% | +6.25% | -17.27% | -34.87% | 384M | |
| +0.12% | -1.05% | +48.56% | +173.18% | 1,060B | |
| +0.37% | -0.71% | +64.20% | +62.14% | 619B | |
| -0.74% | -3.32% | +28.61% | +84.38% | 438B | |
| -1.69% | +0.60% | +29.53% | +24.74% | 333B | |
| +0.27% | -0.38% | +29.23% | +47.30% | 282B | |
| -1.34% | -10.35% | +18.55% | +22.36% | 267B | |
| +0.67% | +1.03% | -26.81% | -37.96% | 218B | |
| -2.00% | -2.77% | +19.96% | +56.51% | 196B | |
| +0.17% | +0.40% | +16.09% | +69.64% | 161B | |
| Average | -0.18% | -2.21% | +21.06% | +46.74% | 357.43B | |
| Weighted average by Cap. | -0.29% | -3.09% | +35.64% | +84.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 321M 280M 259M 239M 453M 30.58B 461M 3.09B 1.21B 15.06B 1.2B 1.18B 51.79B | 1.86B 275M 240M 222M 205M 388M 26.2B 395M 2.65B 1.04B 12.91B 1.03B 1.01B 44.38B |
| Net income | -317M -46.78M -40.92M -37.75M -34.86M -66.15M -4.46B -67.26M -451M -177M -2.2B -176M -172M -7.56B | -330M -48.61M -42.51M -39.21M -36.22M -68.72M -4.64B -69.88M -469M -184M -2.28B -182M -179M -7.85B |
| Net Debt | 411M 60.6M 53.01M 48.89M 45.16M 85.68M 5.78B 87.12M 584M 229M 2.85B 228M 223M 9.79B | 217M 32.02M 28.01M 25.83M 23.86M 45.27M 3.05B 46.04M 309M 121M 1.5B 120M 118M 5.17B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-12 | CN¥3.400 | +2.41% | 36,638,170 |
| 26-07-10 | CN¥3.320 | +5.40% | 35,226,991 |
| 26-07-09 | CN¥3.150 | -0.32% | 13,205,327 |
| 26-07-08 | CN¥3.160 | +0.32% | 15,263,713 |
| 26-07-07 | CN¥3.150 | -4.26% | 18,555,800 |
- Stock Market
- Stocks
- 600594 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
